Delivery Order SPE2DR25D3012-SPE2DR26F4D3D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,857.74 to AmerisourceBergen Drug Corp for the supply of Aminocaproic Acid 500 mg tablets (30-count). This competitively awarded, firm fixed price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among eligible...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $2,457.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Tranexamic 1,000 mg/100ml-NaCl 100ml. This is a non-set-aside contract with a completion date of December 5, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,842.70 to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Acetaminophen 1,000mg/100ml vials (100ml units). This firm fixed-price delivery order, with an ultimate completion date of June 17, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a direct procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,458.73 by the Defense Logistics Agency on December 5, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 29, 2025. This award is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,185.24 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price delivery order, designated as a child contract, represents a discrete pharmaceutical or medical supply transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,321.28 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,566.00 firm fixed-price delivery order for Procainamide 1 gram/10 mL vials on November 24, 2025, with completion targeted for November 25, 2025. The award, which carries no set-aside designation, represents a competitively awarded delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $8,458.73 delivery order to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed-price contract, awarded on December 2, 2025, with an ultimate completion date of December 23, 2025, represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D3DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,156.24 to AmerisourceBergen Drug Corp for the supply of Aminocaproic Acid 1,000 mg tablets in quantities of 30 on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with the DLA to fulfill federal pharmaceutical procurement needs. This delivery order falls under AmerisourceBergen Drug Corp's $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the DLA and other government agencies, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's proven capability to meet federal procurement requirements through open competition and its significant prime contract position position it as a critical vendor for supporting military and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/10/25 |